Kirk Ways
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Ophthalmology top 2%
- Retinal Diseases and Treatments
Papers in
-
- Diabetes Treatment and Management 10
- Diabetes Management and Research 2
-
- Retinal Diseases and Treatments 2
- Co-authors
- Mehul G. Desai (3 shared papers)Gary E. Meininger (3 shared papers)Ngozi Erondu (1 shared paper)Keith Usiskin (3 shared papers)Julio Rosenstock (2 shared papers)Paul Nyirjesy (2 shared papers)George A. Capuano (3 shared papers)George Liang King (2 shared papers)
- Journals
- Diabetes Care (3 papers)Current Medical Research and Opinion (3 papers)Diabetologia (2 papers)Blood (1 paper)Chemico-Biological Interactions (1 paper)
- Partner nations
- United StatesBelgiumAustralia
In The Last Decade
Kirk Ways
22 papers receiving 2.2k citations
Kirk Ways's Hit Papers
Peers
Comparison fields: 5 of 84
- Endocrinology, Diabetes and Metabolism 1.4k
- Ophthalmology 392
- Clinical Biochemistry 42
- Nephrology 84
- Neurology 43
Countries citing papers authored by Kirk Ways
This map shows the geographic impact of Kirk Ways's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk Ways with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk Ways more than expected).
Fields of papers citing papers by Kirk Ways
This network shows the impact of papers produced by Kirk Ways. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk Ways. The network helps show where Kirk Ways may publish in the future.
Co-authors
The 25 scholars most cited alongside Kirk Ways, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitor Hit paper breakdown → | 1997 | 567 |
| 2 | 2015 | 272 | |
| 3 | 2012 | 212 | |
| 4 | 2014 | 204 | |
| 5 | 2012 | 197 | |
| 6 | 2014 | 132 | |
| 7 | 2012 | 127 | |
| 8 | 2004 | 125 | |
| 9 | 2005 | 88 | |
| 10 | 2015 | 80 | |
| 11 | 2012 | 71 | |
| 12 | 1999 | 70 | |
| 13 | 1992 | 64 | |
| 14 | 2004 | 48 | |
| 15 | 1992 | 35 | |
| 16 | 1991 | 31 | |
| 17 | 2014 | 20 | |
| 18 | 1993 | 10 | |
| 19 | 2014 | 10 | |
| 20 | 1987 | 8 |
About Kirk Ways
Kirk Ways is a scholar working on Endocrinology, Diabetes and Metabolism, Ophthalmology, Cancer Research, Infectious Diseases and Immunology, having authored 22 papers that have together received 2.4k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (10 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Antifungal resistance and susceptibility (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Carcinogens and Genotoxicity Assessment (2 papers), Retinal Diseases and Treatments (2 papers), Diabetes Management and Research (2 papers) and Folate and B Vitamins Research (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.4k citations), Ophthalmology (392 citations), Clinical Biochemistry (42 citations), Nephrology (84 citations) and Neurology (43 citations). Kirk Ways has collaborated with scholars based in United States, Belgium and Australia. Frequent co-authors include Mehul G. Desai, Gary E. Meininger, Ngozi Erondu, Keith Usiskin, Julio Rosenstock, Paul Nyirjesy, George A. Capuano, George Liang King, Allen C. Clermont and Chikako Takagi. Their work appears in journals such as Diabetes Care, Current Medical Research and Opinion, Diabetologia, Blood and Chemico-Biological Interactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.